each canister of Breztri Aerosphere is packaged in a foil pouch with desiccant sachet and is placed into a carton. each carton contains one canister and Patient Information. Breztri Aerosphere ...

At the same time, AstraZeneca also launched its latest triple therapy, Breztri Aerosphere® to cater to the unmet needs of patients living with chronic obstructive pulmonary disease (COPD).

Bevespi Aerosphere is the first product approved using AZ's Co-Suspension Technology. This technology enables consistent delivery of one or more different medicines from a single pMDI.

Glycopyrrolate 9mcg, formoterol fumarate 4.8mcg; per inhalation; metered-dose inhaler. LABA as monotherapy (without ICS) for asthma can increase risk of asthma-related events. Do not initiate in ...

AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive ...

Pharmac will also fund osimertinib for people with a type of advanced non-small cell lung cancer. About 20 percent of people with non-small cell lung cancer have a mutation in their cancer that can be ...